safety of glp-1 receptor agonists Potential Use and GIP/GLP-1 for Respiratory Disorders: Where Are We at? The Potential Indirect Impact of
Description
As healthcare systems prioritize chronic disease management, GLP-1 receptor agonists are positioned to remain a critical component of treatment protocols

Resistance training two to three times per week, combined with adequate protein intake, sends muscle-building signals that counteract the catabolic effects of caloric restriction

In collaboration with scientists at CU Boulder and Colorado State University, Paynes lab is part of a moonshot project funded by the federal government aimed at developing a regenerative approach to cure OA
When intestinal lipopolysaccharide (LPS) causes metabolic syndrome, the individuals microbiota metabolites and AhR activity are impaired
